F15063, a potential antipsychotic with dopamine D₂/D₃ antagonist, 5-HT_1A agonist and D₄ partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice

By Assié Marie-Bernadette   Bardin Laurent   Auclair Agnès   Consul-Denjean Nathalie   Sautel François   Depoortère Ronan   Newman-Tancredi Adrian  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 4, 2007-06 ,pp. : 241-250

Springer Publishing Company

Access to resources Recommend Favorite

Preclinical pharmacology of B-20991, a 5-HT 1A receptor agonist with anxiolytic activity

By Beneytez M.E.   Lopez Rodrguez M.L.   Rosado M.L.   Morcillo M.J.   Orensanz L.   Fuentes J.A.   Manzanares J.  

European Journal of Pharmacology, Vol. 344, Iss. 2, 1998-03 ,pp. : 127-135

Elsevier

Access to resources Recommend Favorite

The anxiolytic effects of flesinoxan, a 5-HT 1A receptor agonist, are not related to its neuroendocrine effects

By Groenink L.   Van der Gugten J.   Verdouw P.M.   Maes R.A.A.   Olivier B.  

European Journal of Pharmacology, Vol. 280, Iss. 2, 1995-07 ,pp. : 185-193

Elsevier

Access to resources Recommend Favorite

SDZ NVI 985, an 1A -adrenoceptor agonist with 5-HT 2A receptor antagonist properties

By Lachnit W.G.   Ford A.P.D.W.   Clarke D.E.  

European Journal of Pharmacology, Vol. 297, Iss. 1, 1996-02 ,pp. : 83-86

Elsevier

Access to resources Recommend Favorite

R(+)-8-OH-DPAT, a 5-HT 1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens

By Ichikawa J.   Kuroki T.   Kitchen M.T.   Meltzer H.Y.  

European Journal of Pharmacology, Vol. 287, Iss. 2, 1995-12 ,pp. : 179-184

Elsevier

Access to resources Recommend Favorite